Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 6
Submit an article Journal homepage
393
Views
43
CrossRef citations to date
0
Altmetric
Original Article: Clinical

R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: A pilot study

Giuseppe Visani Hematology and Hematopoietic Stem Cell Transplant Center, San Salvatore Hospital, Pesaro, ItalyCorrespondence[email protected]
,
Felicetto Ferrara Division of Hematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
,
Francesco Alesiani Onco-Hematology Unit, Bartolomeo Eustacchio Hospital, San Severino Marche, Italy
,
Sonia Ronconi Division of Oncology and Diagnostics, Ospedale G.B. Morgagni, Forli, Italy
,
Massimo Catarini Department of Internal Medicine, General Hospital of Macerata, Italy
,
Francesca D'adamo Hematology and Hematopoietic Stem Cell Transplant Center, San Salvatore Hospital, Pesaro, Italy
,
Barbara Guiducci Hematology and Hematopoietic Stem Cell Transplant Center, San Salvatore Hospital, Pesaro, Italy
,
Daniele Bernardi Division of Medical Oncology, Civil Hospital, Vittorio Veneto, Italy
,
Sara Barulli Hematology and Hematopoietic Stem Cell Transplant Center, San Salvatore Hospital, Pesaro, Italy
,
Pierpaolo Piccaluga Institute of Hematology and Medical Oncology, “L. & A. Seràgnoli”, University of Bologna, Bologna, Italy
,
Marco Rocchi Institute of Biomathematics, Urbino University, Urbino, Italy
&
Alessandro Isidori Hematology and Hematopoietic Stem Cell Transplant Center, San Salvatore Hospital, Pesaro, Italy
 show all
Pages 1081-1086 | Received 21 Nov 2007, Accepted 07 Mar 2008, Published online: 01 Jul 2009

Citations (43)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Hongye Gao, Yanfeng Xu, Yanfei Liu, Lan Mi, Xiaopei Wang, Weiping Liu, Jun Zhu & Yuqin Song. (2022) A Comparison of Clinical Prognostic Indices in Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with a Pegylated Liposomal Doxorubicin Combination Regimen in China. Cancer Management and Research 14, pages 2711-2721.
Read now
Ombretta Annibali, Francesca Chiodi, Natalia Cenfra, Chiara Sarlo, Simona Mega, Ilaria Cavallari, Angela Rago, Simona Tomassini, Sergio Mecarocci, Giuseppe Cimino & Giuseppe Avvisati. (2016) ‘Real Life’ experience in a ‘difficult to treat’ patient population of non-Hodgkin lymphomas using the R-COMP regimen. Leukemia & Lymphoma 57:12, pages 2919-2922.
Read now
Emilio Iannitto, Stefano Luminari, Claudio Tripodo, Salvatrice Mancuso, Marina Cesaretti, Luigi Marcheselli, Francesco Merli, Caterina Stelitano, Angelo Michele Carella, Alberto Fragasso, Elisa Montechiarello, Giuseppina Ricciuti, Alessandro Pulsoni, Marco Paulli, Vito Franco & Massimo Federico. (2015) Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study. Leukemia & Lymphoma 56:12, pages 3281-3287.
Read now
Pier Luigi Zinzani, Massimo Federico, Stefano Oliva, Antonello Pinto, Luigi Rigacci, Giorgina Specchia, Alessandra Tucci & Umberto Vitolo. (2015) The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma. Leukemia & Lymphoma 56:1, pages 12-25.
Read now
Giuseppe Visani & Alessandro Isidori. (2009) Nonpegylated liposomal doxorubicin in the treatment of B-cell non-Hodgkin’s lymphoma: where we stand. Expert Review of Anticancer Therapy 9:3, pages 357-363.
Read now

Articles from other publishers (38)

Yangyang Wang, Xiyang Ren, Keke Huang, Xue Liang, Lianfang Pu, Linhui Hu & Zhimin Zhai. (2023) Comparison of first-line treatments for elderly patients with diffuse large B-cell lymphoma: A systematic review and network meta-analysis. Frontiers in Immunology 13.
Crossref
Louise André, Gabriel Antherieu, Amélie Boinet, Judith Bret, Thomas Gilbert, Rabia Boulahssass & Claire Falandry. (2022) Oncological Treatment-Related Fatigue in Oncogeriatrics: A Scoping Review. Cancers 14:10, pages 2470.
Crossref
Carlo Visco, Francesca Pregnolato, Isacco Ferrarini, Beatrice De Marco, Valentina Bonuomo, Eugenio Sbisà, Costanza Fraenza, Andrea Bernardelli, Ilaria Tanasi, Francesca Maria Quaglia & Mauro Krampera. (2021) Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis. Critical Reviews in Oncology/Hematology 163, pages 103377.
Crossref
Mengyang Di, Scott F Huntington & Adam J. Olszewski. (2021) Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients. The Oncologist 26:2, pages 120-132.
Crossref
Juan‐Manuel Sancho, Rubén Fernández‐Alvarez, Francisco Gual‐Capllonch, Esther González‐García, Carlos Grande, Norma Gutiérrez, María‐Jesús Peñarrubia, Ana Batlle‐López, Eva González‐Barca, José‐María Guinea, Eva Gimeno, Francisco‐Javier Peñalver, Miguel Fuertes, Mariana Bastos, José‐Ángel Hernández‐Rivas, José‐María Moraleda, Olga García, Marc Sorigué & Alejandro Martin. (2021) R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group. Cancer Medicine 10:4, pages 1314-1326.
Crossref
Luigi Rigacci, Ombretta Annibali, Sofya Kovalchuk, Elisabetta Bonifacio, Francesca Pregnolato, Francesco Angrilli, Umberto Vitolo, Samantha Pozzi, Serena Broggi, Stefano Luminari, Francesco Merli, Michele Spina, Silvia Bolis, Gloria Margiotta‐Casaluci, Rosario Scalzulli, Christina Cox, Angela Maria Mamusa, Armando Santoro, Pier Luigi Zinzani, Samantha Ferrari, Guido Gini, Maria Luigia Vigliotti, Antonino Mulè & Leonardo Flenghi. (2020) Nonpeghylated liposomal doxorubicin combination regimen ( R‐COMP ) for the treatment of lymphoma patients with advanced age or cardiac comorbidity . Hematological Oncology 38:4, pages 478-486.
Crossref
Vicki A. Morrison. 2020. Geriatric Oncology. Geriatric Oncology 583 612 .
Roland Christian Schelker, Wolfgang Herr, Albrecht Reichle & Martin Vogelhuber. (2018) Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience. BMC Cancer 18:1.
Crossref
Stefano Luminari, Elda Viel, Andrés José Maria Ferreri, Francesco Zaja, Emanuela Chimienti, Gerardo Musuraca, Alessandra Tucci, Monica Balzarotti, Monica Tani, Francesca Salvi, Emanuela A. Pesce, Angela Ferrari, Anna M. Liberati, Antonio Spadea, Dario Marino, Maria Bruno-Ventre, Stefano Volpetti, Chiara Bottelli, Elena Ravaioli, Francesco Merli & Michele Spina. (2018) Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi. Hematological Oncology 36:1, pages 68-75.
Crossref
Giuseppina Ricciuti, Erica Finolezzi, Stefania Luciani, Elena Ranucci, Massimo Federico, Marta Di Nicola, Isaia Antonio Luca Zecca & Francesco Angrilli. (2018) Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study. Hematological Oncology 36:1, pages 44-48.
Crossref
Vicki A. Morrison. 2018. Geriatric Oncology. Geriatric Oncology 1 31 .
Jacopo Olivieri, Gian Piero Perna, Caterina Bocci, Claudia Montevecchi, Attilio Olivieri, Pietro Leoni & Guido Gini. (2017) Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin. The Oncologist 22:4, pages 422-431.
Crossref
Alberto Fabbri, Emanuele Cencini & Monica Bocchia. (2015) Treatment decisions and outcome in very elderly patients with diffuse large B-Cell lymphoma. Cancer 121:20, pages 3746-3747.
Crossref
Sarah Rohlfing, Matthias Aurich, Tilman Schöning, Anthony D. Ho & Mathias Witzens-Harig. (2015) Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac Diseases. Clinical Lymphoma Myeloma and Leukemia 15:8, pages 458-463.
Crossref
V.A. Morrison, P. Hamlin, P. Soubeyran, R. Stauder, P. Wadhwa, M. Aapro & S.M. Lichtman. (2015) Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary. Annals of Oncology 26:6, pages 1058-1068.
Crossref
Yasuhiro Oki, Michael S. Ewer, Daniel J. Lenihan, Michael J. Fisch, Fredrick B. Hagemeister, Michelle Fanale, Jorge Romaguera, Barbara Pro, Nathan Fowler, Anas Younes, Alan B. Astrow, Xuelin Huang, Larry W. Kwak, Felipe Samaniego, Peter McLaughlin, Sattva S. Neelapu, Michael Wang, Luis E. Fayad, Jean-Bernard Durand & M. Alma Rodriguez. (2015) Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial. Clinical Lymphoma Myeloma and Leukemia 15:3, pages 152-158.
Crossref
Nils Winkelmann & Ulrich Wedding. 2015. Management of Hematological Cancer in Older People. Management of Hematological Cancer in Older People 185 202 .
Giuseppe Visani, Federica Loscocco & Alessandro Isidori. (2014) Nanomedicine strategies for hematological malignancies: what is next?. Nanomedicine 9:15, pages 2415-2428.
Crossref
David Mayr & Michael A. Fridrik. (2014) Anthracycline cardiotoxicity and lymphoma. memo - Magazine of European Medical Oncology 7:1, pages 43-46.
Crossref
Francesco Marchesi, Natalia Cenfra, Lidia Altomare, Maria L. Dessanti, Sergio Mecarocci, Elisabetta Cerchiara, Angela Rago, Mariella D'Andrea, Valeria Tomarchio, Odoardo M. Olimpieri, Maria C. Tirindelli, Andrea Mengarelli, Maria C. Petti, Guiseppe Avvisati & Guiseppe Cimino. (2013) A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment. Journal of Geriatric Oncology 4:3, pages 242-248.
Crossref
Antonino Carbone & Anas YounesMichele SpinaRosanna CianciaUmberto Tirelli. 2013. Non-Hodgkin Lymphomas: Advanced Diagnostics & Personalized Therapies. Non-Hodgkin Lymphomas: Advanced Diagnostics & Personalized Therapies 304 319 .
Chalid Assaf, Jürgen C. Becker, Marc Beyer, Antonio Cozzio, Edgar Dippel, Claus-Detlev Klemke, Peter Kurschat, Michael Weichenthal & Rudolf Stadler. (2013) Treatment of advanced cutaneous T-cell lymphomas with non-pegylated liposomal doxorubicin - Consensus of the lymphoma group of the Working Group Dermatologic Oncology. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11:4, pages 338-347.
Crossref
Fabrice Jardin & Hervé Tilly. 2013. Lymphoma. Lymphoma 177 202 .
Frédéric Peyrade, Lauris Gastaud, Daniel Ré, Sandrine Pacquelet-Cheli & Antoine Thyss. (2012) Treatment decisions for elderly patients with haematological malignancies: a dilemma. The Lancet Oncology 13:8, pages e344-e352.
Crossref
Gaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone, Anna Lucania, Maria RosariaVilla, Emanuela Morelli, Alfonso Amore, Gaetana Capobianco, Antonietta Caronna, Cristina Becchimanzi, Francesco Volzone, Gianpaolo Marcacci, Filippo Russo, Rosaria De Filippi, Lucia Mastrullo & Antonio Pinto. (2011) Biweekly rituximab, cyclophosphamide, vincristine, non‐pegylated liposome‐encapsulated doxorubicin and prednisone (R‐COMP‐14) in elderly patients with poor‐risk diffuse large B‐cell lymphoma and moderate to high ‘life threat’ impact cardiopathy. British Journal of Haematology 154:5, pages 579-589.
Crossref
Eva Gimeno, Blanca Sánchez-González, Alberto Álvarez-Larrán, Carmen Pedro, Eugenia Abella, Josep Comín, Silvia Saumell, Francesc García-Pallarols, Miquel Gómez, Carles Besses & Antonio Salar. (2011) Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma. Leukemia Research 35:3, pages 358-362.
Crossref
Antonino Musolino, Daniela Boggiani, Michele Panebianco, Giovanna Vasini, Stefania Salvagni, Vittorio Franciosi & Andrea Ardizzoni. (2010) Activity and safety of dose‐adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor‐prognostic untreated diffuse large B‐cell non‐Hodgkin lymphoma. Cancer 117:5, pages 964-973.
Crossref
Giuseppe VisaniAlessandro Isidori. (2011) Doxorubicin variants for hematological malignancies. Nanomedicine 6:2, pages 303-306.
Crossref
M. Aapro, C. Bernard-Marty, E.G.C. Brain, G. Batist, F. Erdkamp, K. Krzemieniecki, R. Leonard, A. Lluch, S. Monfardini, M. Ryberg, P. Soubeyran & U. Wedding. (2011) Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Annals of Oncology 22:2, pages 257-267.
Crossref
Bo Guo, Hong-Li Zhu, Su-Xia Li, Xue-Chun Lu & Hui Fan. (2011) Individualized Liposomal Doxorubicin-Based Treatment in Elderly Patients with Non-Hodgkin’s Lymphoma. Onkologie 34:4, pages 184-188.
Crossref
Pierre Soubeyran, Hussein Khaled, Marius MacKenzie, Muriel Debois, Catherine Fortpied, Robrecht de Bock, Joel Ceccaldi, Daphne de Jong, Houchingue Eghbali, Muriel Rainfray, Alain Monnereau, Gilbert Zulian & Ivana Teodorovic. (2011) Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly. Journal of Geriatric Oncology 2:1, pages 36-44.
Crossref
Tamás Nagykálnai. (2010) A nem pegilált liposzomális doxorubicin (Myocet®), mint a szabad doxorubicin kevésbé kardiotoxikus alternatívájaNon-pegylated doxorubicin (Myocet®) as the less cardiotoxic alternative of free doxorubicin. Magyar Onkológia 54:4, pages 359-367.
Crossref
S. Luminari, A. Montanini, D. Caballero, S. Bologna, M. Notter, M.J.S. Dyer, A. Chiappella, J. Briones, M. Petrini, A. Barbato, L. Kayitalire & M. Federico. (2010) Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial. Annals of Oncology 21:7, pages 1492-1499.
Crossref
Pierre SoubeyranSimone Mathoulin-PélissierAnna JosninIsabelle SoubeyranMichèle KindMuriel RainfrayBernard Hœrni. (2010) Overview of aggressive lymphomas in the older adult. Aging Health 6:2, pages 191-200.
Crossref
Daniel Heintel, Cathrin Skrabs, Alexander Hauswirth, Karin Eigenberger, Christine Einberger, Markus Raderer, Wolfgang R. Sperr, Paul Knöbl, Leonhard Müllauer, Martin Uffmann, Karin Dieckmann, Alexander Gaiger & Ulrich Jäger. (2009) Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age. Annals of Hematology 89:2, pages 163-169.
Crossref
Miriam Moreno, Juan-Manuel Sancho, Santiago Gardella, Rosa Coll, Olga García, David Gallardo & Josep-María Ribera. (2010) Doxorrubicina liposomal no pegilada en combinación con ciclofosfamida, vincristina, prednisona y rituximab en el tratamiento de linfomas no hodgkinianos: estudio de 26 pacientes. Medicina Clínica 134:2, pages 72-75.
Crossref
Pierre Soubeyran, Cécile Mertens, Carine Bellera, Simone Mathoulin-Pélissier & Muriel Rainfray. (2009) Management of unfit patients with unfavourable non-Hodgkin’s lymphomas. Cancer Treatment Reviews 35:6, pages 528-532.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.